ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 180,72
0,02%
Dow Jones
44 722,06
0,00%
DAX
19 469,78
0,24%
Brent Oil
72,91
0,32%
Bitcoin
97 249,50
1,66%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Bio Path Holdings Inc (BPTH)

  7. Bio Path Holdings Inc (BPTH) Actualités

BPTH

Bio Path (BPTH)

Bio Path Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BPTH
DateHeureSourceTitreSymboleSociété
25/11/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
15/11/202413h00GlobeNewswire Inc.Bio-Path Holdings Reports Third Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
13/11/202417h15Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BPTHBio Path Holdings Inc
08/11/202413h00GlobeNewswire Inc.Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024NASDAQ:BPTHBio Path Holdings Inc
28/10/202421h37Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:BPTHBio Path Holdings Inc
28/10/202421h35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BPTHBio Path Holdings Inc
28/10/202421h32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BPTHBio Path Holdings Inc
23/10/202413h00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BPTHBio Path Holdings Inc
23/10/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BPTHBio Path Holdings Inc
22/10/202421h11Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BPTHBio Path Holdings Inc
18/10/202423h12Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BPTHBio Path Holdings Inc
17/10/202422h37Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
10/10/202423h24GlobeNewswire Inc.Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
09/10/202402h00GlobeNewswire Inc.Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
08/10/202413h00GlobeNewswire Inc.Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of ObesityNASDAQ:BPTHBio Path Holdings Inc
16/09/202413h00GlobeNewswire Inc.Bio-Path Holdings Announces Publication in BiomedicinesNASDAQ:BPTHBio Path Holdings Inc
03/09/202413h00GlobeNewswire Inc.Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:BPTHBio Path Holdings Inc
21/08/202413h00GlobeNewswire Inc.Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid TumorsNASDAQ:BPTHBio Path Holdings Inc
15/08/202413h00GlobeNewswire Inc.Bio-Path Holdings Reports Second Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
14/08/202422h41Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BPTHBio Path Holdings Inc
08/08/202413h00GlobeNewswire Inc.Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024NASDAQ:BPTHBio Path Holdings Inc
02/08/202400h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPTHBio Path Holdings Inc
08/07/202413h00GlobeNewswire Inc.Bio-Path Holdings Provides Clinical Update and Expansion PlansNASDAQ:BPTHBio Path Holdings Inc
14/06/202413h00GlobeNewswire Inc.Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association CongressNASDAQ:BPTHBio Path Holdings Inc
03/06/202413h00GlobeNewswire Inc.Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BPTHBio Path Holdings Inc
24/05/202413h00GlobeNewswire Inc.Bio-Path Holdings to Present Data at 2024 European Hematology Association CongressNASDAQ:BPTHBio Path Holdings Inc
23/05/202423h00GlobeNewswire Inc.Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BPTHBio Path Holdings Inc
15/05/202413h50IH Market NewsU.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices DropNASDAQ:BPTHBio Path Holdings Inc
15/05/202413h00GlobeNewswire Inc.Bio-Path Holdings Reports First Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
08/05/202413h00GlobeNewswire Inc.Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024NASDAQ:BPTHBio Path Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:BPTH

Dernières Valeurs Consultées

BIT
UC8XVT
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés

BLACK FRIDAY

ADVFN

Célébrons nos 25 ans Est 1999-2024

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Cours Euronext en temps réel et illimités sur le site. Carnet d'ordres Euronext en direct